By jguettler In EventsPosted January 22, 2019 Meet with us at Phacilitate Leaders World 2019 Read More
By jguettler In EventsPosted January 7, 2019 Meet with us at the 2019 J.P. Morgan Healthcare Conference Read More
By jguettler In NewsPosted May 16, 2018 Sentien Co-Founder Dr. Biju Parekkadan Gives a Live Interview at World Advanced Therapies & Regenerative Medicine Congress Read More
By jguettler In NewsPosted December 18, 2017 Sentien Co-Founder Dr. Biju Parekkadan Gives TEDx Talk at Rutgers University Read More
By jguettler In NewsPosted October 4, 2017 Sentien CEO Brian Miller Presents at Cell & Gene Therapy Meeting on the Mesa Read More
By jguettler In NewsPosted September 13, 2017 Cell Trials Data Selects Sentien’s Ph 1/2 Study of SBI-101 for AKI as Its Featured Advanced Cell Therapy Trial Read More
By jguettler In NewsPosted June 8, 2017 Sentien Announces Open Enrollment in Phase 1/2 Trial of SBI-101 for Patients with Acute Kidney Injury Read More
By jguettler In EventsPosted May 19, 2017 Sentien Co-Founder Dr. Biju Parekkadan to speak at The Future of Regenerative Medicine Congress Read More
By jguettler In EventsPosted May 16, 2017 Sentien to sponsor and exhibit at the Cellular Therapeutics in Trauma & Critical Care Conference from May 17-19 in San Francisco Read More
By jguettler In EventsPosted May 9, 2017 Sentien Co-Founder Dr. Biju Parekkadan to speak at ASGCT Meeting Read More
